Profession

Discussing the challenges facing small rare disease-focussed biotechs, and the successes of advancing treatments.

From academia in Milan to professional development in the UK, Valo Therapeutics CEO Marcella Origgi shares her journey.

Eli Lilly and Purdue University strengthen their ongoing drug discovery collaboration with further initiatives.

Now that the 2025 Power List is live, we speak with the people working hard every day to make a difference.

Many US researchers are at odds with the imposition of Trump’s political agendas. EU member states are looking to take advantage.

From a love of history books to a love of CRISPR, Monika Paule tells us the story of her career and the origins of Caszyme.

We sat down with Kite’s Cindy Perettie to talk about access to CAR Ts.

From Carl June to Peter Marks to Kiran Mazumdar-Shaw; check out our thought provoking interviews with some of the biggest names in the pharma field.

Simon Tasker joined Colorcon as a bench chemist – and never left. Today, he’s the company’s CEO. Here’s how his career unfolded.

Discussing the development of trends, treatments, and talent in gene therapy with NewBiologix CEO Igor Fisch.